Skip to main content

Table 1 Clinical data of patients with HNSCC

From: Identification of genomic copy number variations associated with specific clinical features of head and neck cancer

  # (%) Median age at diagnosis (range)   Median observation time (range)  
Women 14 (21.9%) 56.5 (48–76) years   13 (2–53) months  
Men 50 (78.1%) 57 (34–78) years   22 (2–61) months  
Deceased 42 (65.6%)     
Status unknown 3 (4.7%)     
Disease reoccurrence 3 (4.7%)     
Tumor locations # (%)     
Oral cavity 34 (53.1%)     
Oropharynx 25 (39.1%)     
Hypopharynx 5 (7.8%)     
TNM classification
Tumor # (%) Lymph node status # (%) Distant metastases # (%)
T1 8 (12.5%) N0 22 (34.4%) M0 61 (95.3%)
T2 16 (25.0%) N1 or higher 42 (65.6%) M1 3 (4.7%)
T3 7 (10.9%)     
T4 33 (51.6%)     
Disease stage # (%)   Histologic grading # (%)  
I 6 (9.4%)   grade 1 12 (18.7%)  
II 8 (12.5%)   grade 2 36 (56.3%)  
III 3 (4.7%)   grade 3 16 (25.0%)  
IVA 37 (57.8%)     
IVB 7 (10.9%)     
IVC 3 (4.7%)     
Cancer treatment applied # (%)     
Radical surgery 13 (20.3%)     
Radical surgery & Chemotherapy & Radiotherapy 13 (20.3%)     
Radical surgery & Radiotherapy 18 (28.1%)     
Chemotherapy & Radiotherapy 10 (15.6%)     
Radiotherapy 8 (12.5%)     
No therapy 2 (3.1%)